NR3C2 and Cirrhosis: In decompensated cirrhosis, compilations of case reports and series describe this therapy as a useful adjunct for refractory ascites, acting synergistically with standard-of-care diuretics: loop diuretics and mineralocorticoid receptor antagonists [53,67,138].